• Fulltext


        Click here to view fulltext PDF

      Permanent link:

    • Keywords


      Disease models; drug discovery; framework in India; human-relevant research; organoids; organon- chip; policy

    • Abstract


      The low translational efficiency of animal models to humans, and the development of new-age methodologiesthat are human-cell based, is fuelling a paradigm change across the globe. In this perspectives paper, wediscuss the current state of research, funding, and regulation in these 21st century technologies, includingorganoids and organ-on-chip in India. Recently, a road-map was drawn by Indian Council for MedicalResearch (ICMR) regarding alternatives to animals in research in India and it also held a special session inJanuary 2018 to discuss latest developments in new human-relevant model systems. We document the regulatoryand research landscape in this field in India. We also discuss the challenges present in this field whichinclude lack of training and skills to handle embryonic or induced pluripotent stem cell (iPSC) lines, fundinglimitations, lack of domestic production of reagents leading to elevated costs, and lack of infrastructure, such asmicrofabrication facilities. In the end, we provide recommendations to enable innovation and application ofhuman-relevant methodologies to develop India as a key player in this arena globally.

    • Author Affiliations



      1. Centre for Predictive Human Model Systems, Atal Incubation Centre-CCMB, Hyderabad 500 039, India
      2. CSIR-Centre for Cellular and Molecular Biology, Hyderabad 500 007, India
      3. Atal Incubation Centre-CCMB, Hyderabad 500 039, India
    • Dates

  • Journal of Biosciences | News

    • Editorial Note on Continuous Article Publication

      Posted on July 25, 2019

      Click here for Editorial Note on CAP Mode

© 2021-2022 Indian Academy of Sciences, Bengaluru.